Skip to main content
. 2014 Jul 1;14:476. doi: 10.1186/1471-2407-14-476

Table 2.

Distribution of patients’ treatment in relation to expression of VEGFR-3 or CXCR4

Characteristic
FLO
 
FLP
 
  n % n %
VEGFR-3 +
22
56.4
17
43.6
VEGFR-3 -
14
46.7
16
53.3
CXCR4 +
13
50
13
50
CXCR4 - 24 54.5 20 45.5